Elyptol, Inc. announces the launch of their company's products in the U.S. Originally founded in Australia, Elyptol offers a full range of botanical skin hygiene and hard surface sanitization products that provide superior performance and positive results in the areas of infection control and disinfecting. Elyptol's products are effective against bacteria, funghi and viruses.
"Our Elyptol brand is transforming hygiene practices in the professional market," says Tim O'Connor, president and CEO. "The Elyptol pure ethanol and eucalyptus oil based formulas provide the highest antimicrobial efficacy while leaving the skin nourished and healthy, which enables usage that is more frequent. We are very excited to launch in the U.S. with our endorsed, environmentally friendly green bio-tech products that avoid competitive toxicities, meet and exceed world standard germ efficacies and transform dermatological outcomes to improve user compliance and usage behavior."
"Elyptol's launch in the U.S. and globally is great news to WHO Private Organizations for Patient Safety (POPS,)" says Didier Pittet, professor of medicine and hospital epidemiologist for the University of Geneva Hospitals, and director of the WHO Collaborating Center on Patient Safety. "With its innovative natural formula that is environmentally friendly, focused on germ efficacy and usage frequency, Elyptol is an evolution in hand hygiene and will assist in cleaner hands which can save lives."
Elyptol has patent applications lodged around its composition of botanical ingredients. Its unique formula of pure ethanol, eucalyptus oil and organic moisturising ingredients kills bacteria and viruses rapidly while protecting the skin. The formula is available in gels, wipes and rubs (sprays).
Source: Elyptol, Inc.
Revolutionizing Infection Prevention: How Fewer Hand Hygiene Observations Can Boost Patient Safety
December 23rd 2024Discover how reducing hand hygiene observations from 200 to 50 per unit monthly can optimize infection preventionists' time, enhance safety culture, and improve patient outcomes.
Tackling Health Care-Associated Infections: SHEA’s Bold 10-Year Research Plan to Save Lives
December 12th 2024Discover SHEA's visionary 10-year plan to reduce HAIs by advancing infection prevention strategies, understanding transmission, and improving diagnostic practices for better patient outcomes.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.